Bio Saga Blog - A Chronicle of Life Sciences & Informatics

Applications are invited for the post of Post Doctoral Fellow for the following time-bound sponsored project as per the details given below: Post :  Post Doctoral Fellow Consolidated fellowship :  As per terms governed by the Wellcome trust DBT India Alliance and National Institute of Immunology (a Minimum of Rs. 40,000/- per month).  Project title :  Exploring the role of a developmental regulator in inflammatory immune response under Wellcome Trust DBT India Alliance Essential Qualification :  a. Must hold a Ph.D Degree (not awarded before 2009), or must already have submitted their thesis towards obtaining a Ph.D degree from a reputed Institute. b. Must have more than Five years of research Experience. c.  Must have proven research expertise/skills in basic biochemistry, cell biology and Molecular Biology, Research Expertise in in vivo animal work is also preferred. d. Must have one publication as first author, in international journal, preferab...

BANGALORE, Indian Researchers have achieved a breakthrough, identifying a protein pathway that triggers cancer in the human body owing to its erratic behaviour. Researchers at Bangalore’s National Centre for Biological Sciences (NCBS) led by Satyajit Mayor and Neha Vyas have identified what is known as the Hedgehog pathway and the ways in which it forms and leads to cancer. The researchers, who have published their work in the journal, Cell, say this pathway is formed when the proteins (called hedgehog), which are separate, get drawn to each other by electrostatic interactions between amino acids present around the proteins. A small cluster of proteins then gets formed and goes on to form a mega-cluster. This travels to other cells and creates effects that are good or bad — the cluster could be normal and help organ regeneration or tissue repair, or the cluster could get hyperactive and affect other cells, which is the sign that cancer is coming. Simply put, the NCBS research indicates...

Roche has reached an agreement with Innovatis to buy the cell analysis company for €15 million ($19.5 million), the Swiss life sciences firm said today. Roche said that the acquisition of the Bielefeld, Germany-based company, which focuses on automated cell analysis solutions including cell counting, viability testing, and cell function, fits with its strategy to strengthen its cell research market offerings. Innovatis will become a fully integrated part of Roche Applied Science, and it will develop and market its products through that part of Roche's diagnostics division. Roceh said that Innovatis' technology will complement its existing cell analysis products and is synergistic with its xCelligence technology, which was launched last year. " Roche has been one of our key customers for many years, in particular since the successful development of our cell analysis technology over 10 years ago," Innovatis CEO Michael Grohmann said in a statement. Roche said it ex...

Invitrogen Corporation and Applera Corporation today announced that their Boards of Directors have approved a definitive merger agreement, under which Invitrogen will acquire all of the outstanding shares of Applera's Applied Biosystems Group a cash and stock transaction valued at $6.7 billion. This strategic combination will create a global leader in biotechnology reagents and systems generating approximately $3.5 billion in combined sales, with significant commercial, operational and technical scale, uniquely positioned to accelerate and drive new discoveries and commercial applications. The combined company will have a major presence in key growth markets and exceptional technical capabilities in the areas of genetic analysis, proteomics , cell biology and cell systems. Following the close of the transaction, the combined organization will be named Applied Biosystems, Inc. and will have its corporate headquarters in Carlsbad, California. Under the terms of the merger agreement, ...